IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
出版年份 2012 全文链接
标题
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 136, Issue 3, Pages 659-671
出版商
Springer Nature
发表日期
2012-10-18
DOI
10.1007/s10549-012-2287-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
- (2012) María Paula Roberti et al. CANCER BIOLOGY & THERAPY
- Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
- (2012) Javier Rodríguez et al. EUROPEAN JOURNAL OF CANCER
- Monoclonal Antibody Therapy of Pancreatic Cancer With Cetuximab
- (2012) Eric Luedke et al. JOURNAL OF IMMUNOTHERAPY
- IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
- (2011) M. P. Roberti et al. BREAST CANCER RESEARCH AND TREATMENT
- Modulation of tumor immunity by therapeutic monoclonal antibodies
- (2011) Riad Abès et al. CANCER AND METASTASIS REVIEWS
- Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
- (2011) E. Mamessier et al. CANCER RESEARCH
- Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
- (2011) S. Platonova et al. CANCER RESEARCH
- Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients
- (2011) N. Azzopardi et al. CLINICAL CANCER RESEARCH
- Role of Common-Gamma Chain Cytokines in NK Cell Development and Function: Perspectives for Immunotherapy
- (2011) Raffaella Meazza et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes
- (2010) Julie A. Y. Billar et al. ANNALS OF SURGICAL ONCOLOGY
- Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
- (2010) Alfonso Sánchez-Muñoz et al. BMC CANCER
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
- (2010) Vivien Béziat et al. PLoS One
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels
- (2008) Michael Boyiadzis et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections
- (2008) Hiroshi Terunuma et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started